BioSpace News Archive

Symvivo Corporation, a clinical-stage biotechnology company advancing a proprietary bacTRL™ gene delivery platform, announced today that it has entered into a research collaboration with Merck Sharp and Dohme Corp. Under the terms of the agreement, Merck receives an option to take an exclusive license to Symvivo’s bacTRL™ platform technology for use in advancing delivery of oral vaccines. “We are excited to

Autobahn Therapeutics, a biotechnology company focused on restoring hope for people affected by CNS disorders, today announced that Kevin Finney, chief executive officer, will present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 12, 2021 at 12:10 p.m. ET. About Autobahn Therapeutics Autobahn Therapeutics is focused on restoring hope for people affected by CNS disorders. Autobahn is leveraging i

The Seasoned Technology Executive Brings the Board Over 40 Years of Experience Driving Market Share Gains and Mission Critical Business Transformations

FDA Extends Shelf Life of Octapharma’s cutaquig ® 16.5% for Adult PI Patients As concerns about the supply of immunoglobulin rise, FDA extends expiration date for certain existing lots already in distribution and all new lots of Octapharma’s SCIg

Phoenix PharmaLabs, a privately-held pre-clinical drug discovery company dedicated to the development of potent, non-addictive treatments for pain and addiction, today announced it has completed a license agreement with the University of Bath in England for exclusive rights to a portfolio of 25 NOP (Nociceptin) compounds. The specific terms of the license agreement were not disclosed. One of the compounds, formerly kn

ResMed Announces Participation in the 39 th Annual J.P. Morgan Healthcare Conference

Marrone Bio Innovations, Inc. (Nasdaq: MBII ) (MBI), a leading provider of effective and environmentally responsible pest management and plant health products, announced today that its Form S-3 resale registration statement relating to the potential resale of shares of common stock, including common stock issuable upon the exercise of warrants held by certain shareholders per the Company’s previously announced warrant transaction, has been d

Company Continues Elucidation of Immunological Mechanisms of QuadraMune™ Nutraceutical Currently in Clinical Trials for COVID-19 Prevention

Children’s Hospital of Philadelphia announced it will name the emergency department in its new inpatient hospital in King of Prussia, PA after the late Madlyn K. Abramson, supported by a $2.5 million gift from The Abramson Family Foundation.

Platform offers first of its kind service based on a 300+ radiologist network and over 20 FDA 510(k)-cleared artificial intelligence algorithms to support medical diagnostic industry